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Abstract
Summary Retrospective and prospective population-based survey in a region of the Republic of Kazakhstan determined the
incidence of fractures at the hip, proximal humerus and distal forearm. The hip fracture rates were used to create a FRAX®model
to enhance fracture risk assessment in Kazakhstan.
Objective This paper describes the epidemiology of osteoporotic fractures in the Republic of Kazakhstan that was used to
develop a country specific FRAX® tool for fracture prediction.
Methods We carried out a retrospective population-based survey in Taldykorgan in the Republic of Kazakhstan representing approx-
imately 1% of the country’s population. Hip, forearm and humerus fractures were identified retrospectively in 2015 and 2016 from
hospital registers and the trauma centre. Hip fractures were prospectively identified in 2017 from the same sources and additionally
from primary care data. Age- and sex-specific incidence of hip fracture and national mortality rates were incorporated into a FRAX
model for Kazakhstan. Fracture probabilities were compared with those from neighbouring countries having FRAX models.
Results The difference in hip fracture incidence between the retrospective and prospective survey indicated that approximately 25%
of hip fracture cases did not come to hospital attention. The incidence of hip fracture applied nationally suggested that the estimated
number of hip fractures nationwide in persons over the age of 50 years for 2015 was 11,690 and is predicted to increase by 140% to
28,000 in 2050. Hip fracture incidence was a good predictor of forearm and humeral fractures in men but not in women.
Conclusion The FRAX model should enhance accuracy of determining fracture probability among the Kazakh population and
help guide decisions about treatment.
Keywords FRAX . Fracture probability . Epidemiology . Hip fracture . Forearm fracture . Humerus fracture . Kazakhstan
Introduction
Osteoporosis is a common, chronic and costly condition; its
only clinical consequence is fracture. In Europe, the annual
cost of fractures associated with osteoporosis exceeded € 37
billion in 2010 [1], and disability due to osteoporosis was
greater than that caused by any single cancer, with the excep-
tion of lung cancer and was comparable or greater than that
lost to a variety of chronic noncommunicable diseases, such as
rheumatoid arthritis, asthma and high blood pressure related to
heart disease [2]. Fortunately, a wide variety of treatments is
available that favourably affect bone mass and thereby de-
crease the risk of fractures associated with osteoporosis [3].
The use of such interventions by health care practitioners is
assisted by instruments that assess patients’ fracture risk to
optimize clinical decisions about prevention and treatment.
The most widely used web-based tool FRAX® (https://
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www.sheffield.ac.uk/FRAX/) meets these requirements and
computes the 10-year probability of fragility fractures based
on several common clinical risk factors and optionally a DXA
scan result [4, 5]. FRAXmodels are available for 66 countries
in 2020 covering more than 80% of the world population at
risk [6], and have been incorporated into more than 100 guide-
lines worldwide [7].
The availability of FRAX has stimulated studies that can be
used for the generation of new FRAXmodels. Specific exam-
ples include Brazil, Mexico and Turkey [8]. The present study
is a component part of the Multicenter Multinational
population-based Study in Eurasian Countries (EVA study or
ЭВА, in Russian). The broad aim of the study was to provide
epidemiological information on fracture risk so that FRAX
models could be created for Russia [9], Armenia [10],
Belarus [11], Moldova [12], Kazakhstan and Uzbekistan.
The present report describes the epidemiology of fractures at
the hip, forearm and humerus in Kazakhstan and the genera-
tion of a country specific FRAX model.
Methods
The Republic of Kazakhstan is the world’s largest landlocked
country and the ninth largest in the world, with an area of
2,724,900 km2. Kazakhstan shares borders with Russia,
China, Kyrgyzstan, Uzbekistan, Turkmenistan, and the
Caspian Sea. In 2015 the population of Kazakhstan was
17.75 million and rose to 18.20 million in 2017 [13].
For the present study, Taldykorgan (Taldıqorğan), the ad-
ministrative centre of Almaty Region of Kazakhstan, was cho-
sen as the catchment area. Taldykorgan was selected because
of its long distance from other major cities of the Republic and
the availability of highly specialized orthopaedic care for all
Taldykorgan residents. This minimized the possibility of res-
idents seeking medical care for their fracture in neighbouring
cities. Each individual in Kazakhstan has a unique digital code
which permits the number of residents to be determined by
region, age and sex, the precise number of inhabitants
counting in any period of time [14]. The total catchment pop-
ulation of the regions was 165,296 representing 0.9% of the
total population. The age, sex and ethnic distribution were
very similar to that of the whole country. The ethnic distribu-
tion was Kazakhs (66.5%), Russian (20.6%) and other ethnic-
ities (12.9%) [14].
The study was organized in two phases. The first was a
retrospective survey from 1 January 2015 to 31 December
2016 which captured data on data on fractures at the hip
(ICD-10 codes S72.0, S72.1, S72.2), distal forearm (S52.5,
S52.6) and proximal humerus (S 42.2). The second phase
was a prospective survey from 1 March 2017 to 28 February
2018 that acquired data on hip fracture alone.
In both phases, the medical records of all fractures in men
and women aged 40 years or older were retrieved from the
inpatient electronic health register (EHR) of the three hospitals
in the area, the outpatient register of the City Trauma centre. In
addition, refusals of hospitalization (formal documents) were
examined from all the hospitals of the city. Only fractures
validated by radiographs were included. To avoid double
counting, further admissions for the same fracture site in the
observation time were excluded. In some documents, fracture
ICD-10 code was not specified. In such cases, radiographs
were retrieved and fractures, if verified, were included in the
database. Permanent residence in the region was a criterion for
inclusion. All hip fracture cases were included irrespective of
high or low energy trauma. We excluded pathological frac-
tures attributable to cancer with metastases or to multiple
myeloma.
The prospective study identified new cases of hip fractures
using the same methodology as in the retrospective survey. In
addition, data were gathered from the records of the emergen-
cy call centre, from the records of home visits to patients by
orthopaedic doctors from the outpatient polyclinic, the records
and outpatient electronic health records of all (32) primary
care doctors in the city and two private primary health care
centres to find additional non-hospitalized patients. These pa-
tients were examined at home, and the hip fracture was veri-
fied clinically, and where possible, by radiography.
Yearly incidence rates for fractures of the distal forearm
and proximal humerus were estimated from the number of
men and women in 5- or 10-year age intervals with at least
one index fracture in 2015 and 2016 divided by the age- and
sex-specific population at risk. In the case of hip fracture, the
prospective study identified more men and women than the
retrospective surveys of 2015 and 2016. For example, 65 hip
fracture cases were identified in women in 2015 and 65 in
2016. In contrast, an additional 19 fractures were identified
in 2017 (i.e. a total of 84 hip fractures). We assumed that a
similar number of fractures (19) had been missed in 2015 and
2016 and uplifted the incidence rates in these years by 29%
((65 + 19)/65). In the case of men, the incidence was upward
revised by 8%.
The adjusted age and sex-specific incidence in 2015–2017
was applied to the Kazakh population in 2015 to estimate the
number of hip fractures nationwide. Additionally, future pro-
jections were estimated up to 2050 assuming that the age- and
sex-specific incidence remained stable. Population demogra-
phy was taken from the United Nations using the medium
variant for fertility [15].
The adjusted data on hip fracture were used to construct the
FRAX model. For other major osteoporotic fractures (clinical
spine, forearm and humeral fractures), it was assumed that the
age- and sex-specific ratios of these fractures to hip fracture,
risk found in Sweden were comparable to those in
Kazakhstan. This assumption has been used for many of the
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FRAX models with incomplete epidemiological information.
Available information suggests that the age- and sex-stratified
pattern of fracture is very similar in the Western world,
Australia and Eastern Europe [12, 16–18]. In order to test this
further, we compared the incidence of a forearm or humeral
fracture observed in Kazakhstan with the incidence that would
be predicted from the pattern of incidence inMalmo applied to
the incidence of hip fracture in Kazakhstan. This assumes that
the age- and sex-specific pattern of incidence of proximal
humerus and forearm fracture (i.e. other major fractures,
OMF) and the adjusted hip fracture (HF) in Kazakhstan are
similar to that seen inMalmo [16]. Thus, for each age and sex,
HFKazakhstan
HFMalmo
¼
OMFKazakhstan
OMFMalmo
therefore,
OMFKazakhstan ¼
HFKazakhstan  OMFMalmo
HFMalmo
From this, the incidence of a forearm or humerus fracture,
estimated using the Malmo ratios, was compared with the
empirical data from Kazakhstan from the ages of 50–90 years.
The development and validation of FRAX have been ex-
tensively described [4, 5]. The risk factors used were based on
a systematic set of meta-analyses of population-based cohorts
worldwide and validated in independent cohorts with over 1
million patient-years of follow-up. The construct of the FRAX
model for Kazakhstan retained the beta coefficients of the risk
factors in the original FRAXmodel with the incidence rates of
hip fracture and mortality rates for Kazakhstan. National mor-
tality rates used data from the World Health Organization for
2015 [19]. Ten-year fracture probabilities were compared to
those of neighbouring countries where a FRAX model was
available (China and Russia).
In order to compare Kazakh hip fracture probabilities with
those of other regions of the world, the remaining lifetime
probability of hip fracture from the age of 50 years was cal-
culated for men and women, as described previously [20]. In
the present analysis, values for Kazakhstan were compared
with those of China (with and without inclusion of Hong
Kong), Canada, Denmark, Finland, France, Hungary,
Mexico, Moldova, Poland, Portugal, Russia, Spain, Sweden,
Turkey, Ukraine, the UK and the USA.
Results
A total of 1058 fractures were identified in individuals aged
40 years or more. These comprised 348 hip fractures (2015,
2016 and 2017), 174 humerus and 536 distal forearm fractures
(2015 and 2016).
Hip fracture
A total of 134 hip fractures were identified in men and 214 in
women (female/male ratio 1.6). Below the age of 70 years, hip
fractures were more common in men than in women (female/
male ratio 0.8) but thereafter were more frequent in women
(female/male ratio 3.1). The incidence of hip fracture in-
creased with age in men and women, though more markedly
in women (Table 1). Of the 348 cases of hip fractures, 82 cases
formally (24%) refused hospital admission (27 men and 55
women). The cases that declined admission increased in fre-
quency with age. Of the 266 patients admitted to the hospital,
200 (75%) underwent surgery. In total 43% of hip fracture
cases were either untreated or managed conservatively.
Table 1 Population of the catchment area, number of hip fractures and
annual incidence of hip fractures (rate/100,000) in men and in women
from Taldykorgan, Kazakhstan by age for 2015, 2016 and 2017
combined
Age (years) Population Fracturesa Incidence/
100,000b
95% CI
Men
40–44 15,668 10 67 31–117
45–49 14,234 9 68 29–120
50–54 13,691 10 77 35–134
55–59 11,371 18 167 101–261
60–64 8377 18 225 127–353
65–69 6387 23 378 241–562
70–74 3279 8 254 105–481
75–79 2665 13 527 287–884
80–84 1323 10 780 362–1390
85–89 593 12 2078 1046–3605
90–94 211 3 1536 289–4156
95 + 150 0 – –
40 + 77,949 134 181 152–213
Women
40–44 19,142 5 31 8–61
45–49 17,874 4 271 6–57
50–54 17,099 6 42 17–84
55–59 15,231 14 109 60–176
60–64 11,984 16 158 89–247
65–69 10,058 25 292 193–418
70–74 5169 21 502 313–736
75–79 5665 44 925 692–1212
80–84 2833 38 1515 1096–2042
85–89 1360 31 2663 1867–3684
90–94 357 10 3207 1537–5514
95+ 108 0 – –
40+ 106,880 214 236 207–266
aUnadjusted numbers
b Includes adjusted incidence for 2015 and 2016
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Forearm and humeral fractures
Fractures at the distal forearm were more frequent in women
than in men (female/male ratio = 4.3). There was no clear age-
dependent trend of incidence in women or men (Table 2).
The annual incidence of proximal humerus fractures was
lower in men than in women (female/male ratio = 2.6).
Humeral fractures were less common than forearm fractures,
and in women, increased with age.
Fracture projections
Assuming that the fracture rates in Taldykorgan was represen-
tative for the whole country, and based on the UN estimates of
Kazakh population for 2015, we estimated that the annual
number of hip fractures in men and women age 50 years and
older in Kazakhstan in 2015 was 11,690, comprising 3815 in
men and 7875 fractures in women. The number of hip frac-
tures is expected to increase progressively by calendar year
with an increase of 140% by 2050 (Table 3). The increase in
hip fracture numbers is particularly great in women (153% in
women and 112% in men) due to the high age dependency of
hip fracture incidence.
Fracture probability
In men, the incidence of forearm and humeral fractures was
very similar to that predicted from the epidemiology of frac-
ture in Malmo (Table 4). In women, however, the observed
fracture rates exceeded those predicted from theMalmo ratios,
in some cases significantly so (Table 4). Because of the dis-
cordance in the findings between men and women, the FRAX
model was based on the data on hip fracture, and the assumed
incidence of the other major osteoporotic fractures was deter-
mined from the Malmo ratios.
The 10-year probability of major osteoporotic fracture
and hip fracture in Kazakhstan and neighbouring coun-
tries is shown in Fig. 1 in women with a prior fracture
by age. Ten-year probabilities were consistently higher
than in the neighbouring country of China. In the case
of Russia, 10-year probabilities of a major fracture were
similar to those of Kazakhstan, but for hip fracture, the
probabilities in Russia were substantially lower than those
in Kazakhstan.
Lifetime probabilities for hip fracture are shown in Table 5.
As it was the case for 10-year probabilities, lifetime probabil-
ity of hip fracture was higher than that of Russians or Chinese
but substantially lower than rates in Western Europe and
North America.
Table 2 Number and annual
incidence of forearm and humeral
fractures (rate/100,000) in men
and women in Taldykorgan,
Kazakhstan by age for 2015 and
2016 combined
Forearm Humerus
Age (years) Fractures Incidence 95% CI Fractures Incidence 95% CI
Men
40–49 38 192 136–264 13 66 35–113
50–59 38 229 162–315 18 109 64–172
60–69 20 206 126–318 15 154 86–255
70–79 3 78 16–226 2 52 6–187
80–89 2 1658 20–598 0 – –
90 + 0 1 424 8–2364
40 + 101 197 160–239 49 95 71–126
Women
40–49 90 366 294–450 14 57 31–96
50–59 172 8046 689–934 35 164 114–228
60–69 97 6736 546–821 39 271 192–370
70–79 53 743 556–971 21 294 182–450
80–89 20 748 457–1156 16 599 342–972
90 + 3 952 196–2785 0 – –
40 + 435 617 560–678 125 177 148–211
Table 3 Estimated total number of hip fractures (ICD-10 codes S72.0,
S72.1 and S72.2) in men and in women age 50 years and older in 2015
projected up to 2050 in Kazakhstan
2015 2020 2030 2040 2050
Men 3815 4298 5234 6645 8110
Women 7875 8653 11,293 15,837 19,938
Total 11,690 12,951 16,527 22,482 28,048
Increase (%) – 11 41 92 140
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Discussion
This study documented the incidence of hip, distal forearm
and proximal humeral fractures in a region of Kazakhstan.
As expected, hip fractures were more frequent in women
than in men (female/male ratio = 1.6). In both sexes, the
incidence increased with age. It is of interest that for indi-
viduals younger than 70 years, the hip fracture rate among
men was slightly higher than in women. Thereafter, inci-
dence was higher in women. Similar results have been re-
ported in several studies [24, 26–28] including other coun-
tries of the EVA project, namely Armenia [10], Belarus [11],
Moldova [12] and Russia [9]. Assuming that the regional
incidence was similar to the national incidence, Kazakhstan
belongs to the moderate-risk countries for hip fracture for
men and women [29].
The number of hip fractures nationwide was estimated at
11,690 in 2015.
Demographic projections indicate that the annual number of
hip fractures will increase by 140% to 28,048 in 2050. These
estimates are relatively robust in that all individuals who will be
aged 60 years, or more in 2050 are currently adults. However,
these estimates may be conservative since they assume that the
age- and sex-specific risk of hip fracture remains unchanged over
this period. If the age- and sex-specific incidence of hip fracture
increases, as has been registered in several countries [30], then
the number of fractures may be more than doubled. Such projec-
tions are important for healthcare planning.
The access to all medical records in this study, including
those from primary care, permitted the identification patients
with hip fracture who were not admitted to hospital. The rea-
son for this strategy was the observation that many patients in
Eastern Europe are not hospitalized because facilities for sur-
gical management are limited so that hospital admission is not
feasible. In Belarus, for example, 29% cases of hip fracture did
not come to hospital attention [11]. High rates of non-
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Fig. 1 Ten-year probability of a major osteoporotic fracture (left hand panel) and hip fracture (right) in women with a prior fracture by age from
Kazakhstan, Russia and China. Body mass index set to 25 kg/m2
Table 4 The annual incidence
(/100,000) of forearm and
humeral fractures in women
predicted from the epidemiology
in Malmo (see methods) and that
observed in the present study with
95% confidence intervals (CI)
Age (years) Forearm Humerus
Predicted Observed 95% CI Predicted Observed 95% CI
Men
50–59 298 229 162–315 113 109 64–172
60–69 286 206 126–318 103 154 85–255
70–79 85 78 16–226 128 52 6–187
80–89 79 165 20–598 100 0 0–305
Women
50–59 516 804 689–934 148 164 114–228
60–69 497 673 546–821 188 271 192–370
70–79 640 743 556–971 332 294 182–450
80–89 507 748 457–1156 338 599 342–972
The observations in bold denote a significant difference between observed and predicted estimates
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admittance have been reported in Armenia (44%) [10],
Pervouralsk in Russia (27%) [9], Georgia (75%) and
Kyrgyzstan (50%) [31]. The present study indicated that
25% of hip fracture cases were not admitted to hospital, and
43% of hip fracture cases were either untreated or managed
conservatively. The treatment gap arises for many reasons
including a lack of emergency orthopaedic surgeons. These
findings are important for healthcare planning; they also em-
phasize the importance of exploring care pathways in the de-
sign of epidemiological studies.
A minority of countries that have a FRAXmodel also have
robust information on the risk of other major osteoporotic
fractures. In the absence of such information, FRAX models
are based on the assumption that the age- and sex-specific
pattern of these fractures is similar to that observed in
Malmo [16]. This assumption has been shown to be safe in
studies reported from Canada [18], Iceland [17], the USA
[32], the UK [33], Australia [34] and Moldova [12], despite
the differences in incidence between these countries [29]. This
commonality of pattern is supported by register studies, which
indicate that in those regions where hip fracture rates are high,
so too is the risk of forearm fracture and spine fractures (re-
quiring hospital admission) [35–37].
The acquisition of data on the incidence of forearm and
humerus fractures as well as for hip fracture permitted the
adequacy of this assumption to be tested in the present study,
at least for forearm and humeral fractures. Our findings sug-
gest that the incidence of forearm and humerus fractures can
be reasonably predicted from the incidence of hip fracture in
men. In women, however, the observed fracture rates
exceeded those predicted from the Malmo ratios, in some
cases significantly so. This disparity may arise because hu-
meral and distal forearm fractures are relatively more common
than hip fractures in women from Kazakhstan than in other
counties. Unexpectedly, high rates of forearm and humeral
fractures have been reported in Russia [9] and Hungary [27].
An alternative explanation is that not all cases of hip fracture
were identified, particularly in women. The present study
could not address the alternatives.
The incidence of hip fracture was used to create a FRAX
tool to compute the 10-year probabilities of hip and major
osteoporotic fracture in Kazakhstan. Ten-year probabilities
were consistently higher than in the neighbouring country of
China but for major osteoporotic fractures similar to that re-
ported for Russia.
The widespread availability of FRAX has resulted in its
adoption in many practice guidelines worldwide [7]. The frac-
ture probability equivalent to a woman with a prior fracture
has been used as an intervention threshold in more than 30
countries. If the same threshold were applied to Kazakhstan,
then intervention would be recommended with a probability
of a major fracture that varied between 9.7 and 25% depend-
ing on age (see Fig. 1). The impact of such thresholds or
alternative thresholds will require further study.
There are a number of additional limitations to this study.
With regard to fracture incidence, we examined only about 1%
of the Kazakh population from a single centre. Therefore, the
extrapolation of this regional estimate to the entire country is an
assumption that we were unable to test. In addition to large
variations in fracture rates around the world, fracture rates may
vary within countries. In addition to ethnic-specific differences
[38], up to two-fold differences in hip fracture incidence have
been reported using common methodology with the higher rates
in urban communities including Croatia [39], Switzerland [40],
Norway [41], Argentina [42] and Turkey [43]. No distinction
was made in the level of trauma. However, the division between
high and low trauma is problematic in that osteoporotic patients
fracture more commonly than non-osteoporotic patients follow-
ing high trauma [44, 45].Additionally, BMD is similar in patients
with hip fracture, irrespective of the level of trauma [46]. These
data support the inclusion of high-trauma fractures in epidemio-
logical assessment.
Table 5 Life-time probability of hip fracture in the Kazakh population
from the age of 50 years compared with selected countries
Country Life-time risk at 50 years %
Women Men
Sweden 25.6 11.0
Denmark 23.0 11.3
France 19.3 5.9
China (Hong Kong) 17.7 7.6
USA (Caucasian) 16.1 7.5
Turkeya 15.9 3.6
Canada 15.5 5.8
Greece 15.4 6.8
UK 14.4 5.0
Portugal 13.7 4.8
Finland 12.9 6.0
Kazakhstanb 12.6 6.0
Spain 12.6 4.2
Bulgaria 11.2 4.4
Hungary 10.8 4.2
Mexicoc 10.6 5.0
Polandd 10.1 4.2
Moldovae 9.3 5.7
Russiaf 7.7 3.8
Serbia 7.6 3.7
Romaniag 7.1 3.8
China 5.9 3.3
Ukraineh 5.6 2.9
abcdefgh From [20] except where indicated; Tuzun et al. 2011 [21]; This
study; Clark et al., 2005 [22]; Czerwinski et al., 2009 [23]; Zakroyeva
et al. 2019 [12]; Lesnyak et al. 2012 [9]; Grigorie et al. 2013 [24];
Povoroznyuk et al. 2017 [25]
   30 Page 6 of 8 Arch Osteoporos           (2020) 15:30 
As noted above, it is possible that not all hip fractures were
captured, an effect that would give rise to a systematic under-
estimate of fracture probabilities for both hip fracture and
major osteoporotic fracture. It is relevant, however, that accu-
racy errors have little impact on the rank order with which the
FRAX tool categorizes risk in a given population [10, 25, 47],
but they do change the absolute number generated, and thus
have implications where treatment guidelines are based on
cost-effectiveness or the economic burden of disease.
In summary, a FRAX model has been created for the
Republic of Kazakhstan that based on a regional population-
based estimate of the incidence of hip fracture. The model
should enhance accuracy of determining fracture probability
among the Kazakh population and help to guide decisions
about treatment.
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